Last reviewed · How we verify
1 month Rifapentine, Isoniazid and Vitamin B6 — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
1 month Rifapentine, Isoniazid and Vitamin B6 (1 month Rifapentine, Isoniazid and Vitamin B6) — Rutgers, The State University of New Jersey.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 1 month Rifapentine, Isoniazid and Vitamin B6 TARGET | 1 month Rifapentine, Isoniazid and Vitamin B6 | Rutgers, The State University of New Jersey | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 1 month Rifapentine, Isoniazid and Vitamin B6 CI watch — RSS
- 1 month Rifapentine, Isoniazid and Vitamin B6 CI watch — Atom
- 1 month Rifapentine, Isoniazid and Vitamin B6 CI watch — JSON
- 1 month Rifapentine, Isoniazid and Vitamin B6 alone — RSS
Cite this brief
Drug Landscape (2026). 1 month Rifapentine, Isoniazid and Vitamin B6 — Competitive Intelligence Brief. https://druglandscape.com/ci/1-month-rifapentine-isoniazid-and-vitamin-b6. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab